Literature DB >> 34044068

The E2F1/USP11 positive feedback loop promotes hepatocellular carcinoma metastasis and inhibits autophagy by activating ERK/mTOR pathway.

Lijun Qiao1, Qiangnu Zhang1, Zhe Sun1, Quan Liu2, Zongze Wu2, Weibin Hu2, Shiyun Bao2, Qinhe Yang3, Liping Liu4.   

Abstract

Deubiquitinase ubiquitin-specific protease 11 (USP11), a member of the deubiquitinating family, plays an important but still controversial role in cancer development. Namely, USP11 has been shown to promote the proliferation and metastasis of hepatocellular carcinoma (HCC), but the underlying molecular basis is poorly understood. This study aimed to unravel novel functions of USP11 in HCC, especially those related to autophagy. Here, EdU, migration and colony formation assays, and mouse models showed that USP11 played a crucial role in HCC cell proliferation and metastasis in vitro and in vivo. Results from co-immunoprecipitation and ubiquitination assays demonstrated that USP11 interacted with E2F1 and maintained E2F1 protein stability by removing its ubiquitin. Notably, E2F1 regulated USP11 expression at the transcriptional level. Thus, the E2F1/USP11 formed a positive feedback loop to promote the proliferation and migration of HCC cells. Moreover, E2F1/USP11 inhibited autophagy by regulating ERK/mTOR pathway. In addition, the combination treatment inhibition of USP11 and autophagy enhanced the apoptosis of HCC cells and inhibited the tumor growth in mice more effective than either treatment alone. Taken together, these results indicate that the E2F1/USP11 signal axis promotes HCC proliferation and metastasis and inhibits autophagy, which provides an experimental basis for the treatment of HCC.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; E2F1; Hepatocellular carcinoma; USP11

Mesh:

Substances:

Year:  2021        PMID: 34044068     DOI: 10.1016/j.canlet.2021.05.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma.

Authors:  Yingyi Liu; Ye Yao; Bo Liao; Hao Zhang; Zhangshuo Yang; Peng Xia; Xiang Jiang; Weijie Ma; Xiaoling Wu; Chengjie Mei; Ganggang Wang; Meng Gao; Kequan Xu; Xiangdong GongYe; Zhixiang Cheng; Ping Jiang; Xi Chen; Yufeng Yuan
Journal:  Int J Biol Sci       Date:  2022-06-21       Impact factor: 10.750

2.  USP11 regulates autophagy-dependent ferroptosis after spinal cord ischemia-reperfusion injury by deubiquitinating Beclin 1.

Authors:  Yuluo Rong; Jin Fan; Chengyue Ji; Zhuanghui Wang; Xuhui Ge; Jiaxing Wang; Wu Ye; Guoyong Yin; Weihua Cai; Wei Liu
Journal:  Cell Death Differ       Date:  2021-11-27       Impact factor: 12.067

3.  A novel machine learning derived RNA-binding protein gene-based score system predicts prognosis of hepatocellular carcinoma patients.

Authors:  Qiangnu Zhang; Yusen Zhang; Yusheng Guo; Honggui Tang; Mingyue Li; Liping Liu
Journal:  PeerJ       Date:  2021-12-20       Impact factor: 2.984

4.  ERK-mediated Cytoplasmic Retention of USP11 Contributes to Breast Cancer Cell Proliferation by Stabilizing Cytoplasmic p21.

Authors:  Ling Li; Tanggang Deng; Lin Zhang; Yanpeng Wang; Yangyang Zhou; Yan Liu; Hui Li; Jing Dai; Yuan Yang; Neng Ling; Huimin Liu; Jing Liu; Lanqin Cao; Min Xu; Mao Ye
Journal:  Int J Biol Sci       Date:  2022-03-21       Impact factor: 6.580

5.  The nociceptin receptor promotes autophagy through NF-kB signaling and is transcriptionally regulated by E2F1 in HCC.

Authors:  Xiaoshuang Zhou; Dongtai Chen; Yan Yan; Qiang Li; Wei Xing; Yanling Liu; Yonghua Chen; Dongyin Wang; Yunfei Yuan; Jingdun Xie; Weian Zeng; Jiahao Pan
Journal:  Cell Death Discov       Date:  2022-04-05

Review 6.  Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management.

Authors:  Yihao Liao; Diansheng Zhou; Pu Wang; Mengyue Yang; Ning Jiang
Journal:  Cell Death Discov       Date:  2022-06-17

7.  E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma.

Authors:  Zhibo Tan; Min Chen; Feng Peng; Pengfei Yang; Zhaoming Peng; Zhe Zhang; Xin Li; Xiaopeng Zhu; Lei Zhang; Yujie Zhao; Yajie Liu
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.